CONSENSUS B Tat-22 includes an extended sequence with dense basic residues driving strong electrostatic interactions. Its conformational plasticity allows detailed analysis of Tat-mediated delivery. The peptide is suited for studying structural determinants of nucleic-acid recognition. Research uses include translocation modeling, analog design, and protein-interface mapping.
CAT No: H09532
4. Autoinhibition and phosphorylation-induced activation of phospholipase C-γ isozymes
5. Implications of ligand-receptor binding kinetics on GLP-1R signalling
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More